Skip to main content

Augusto D. Pichard, MD, FACC, FSCAI

Original Contribution
09/05/2009
ABSTRACT: Background. Stents are used to treat the first and even successive episodes of in-stent restenosis (ISR). Methods. In 18 patients (19 lesions), intravascular ultrasound (IVUS) was performed after placement of a stent for a...
ABSTRACT: Background. Stents are used to treat the first and even successive episodes of in-stent restenosis (ISR). Methods. In 18 patients (19 lesions), intravascular ultrasound (IVUS) was performed after placement of a stent for a...
ABSTRACT: Background. Stents are...
09/05/2009
Journal of Invasive Cardiology
Clinical Editor's Corner
09/05/2022
INOCA and MINOCA (myocardial infarction with normal coronary arteries) are now widely known and gathering attention regarding their diagnosis and treatment. Many labs now have sensor guidewires and software to make this possible. Specialized...
INOCA and MINOCA (myocardial infarction with normal coronary arteries) are now widely known and gathering attention regarding their diagnosis and treatment. Many labs now have sensor guidewires and software to make this possible. Specialized...
INOCA and MINOCA (myocardial...
09/05/2022
Cath Lab Digest
09/07/2015
Dr. Andrew Michaels asks whether his practice of moving to micropuncture needle technique for pericardiocentesis is also being employed across the nation.   
Dr. Andrew Michaels asks whether his practice of moving to micropuncture needle technique for pericardiocentesis is also being employed across the nation.   
Dr. Andrew Michaels asks whether...
09/07/2015
Cath Lab Digest
Original Contribution
06/28/2011
ABSTRACT: Background. The process of in-stent neointimal hyperplasia (NIH) between drug-eluting stents (DES) and bare metal stents (BMS) might be different. We compared in vivo composition of in-stent NIH between DES and BMS using virtual...
ABSTRACT: Background. The process of in-stent neointimal hyperplasia (NIH) between drug-eluting stents (DES) and bare metal stents (BMS) might be different. We compared in vivo composition of in-stent NIH between DES and BMS using virtual...
ABSTRACT: Background. The...
06/28/2011
Journal of Invasive Cardiology
Technology Pulse
09/10/2010
Can you share some of your long history with OCT and describe this technology?
Can you share some of your long history with OCT and describe this technology?
Can you share some of your long...
09/10/2010
Cath Lab Digest
02/03/2015
Do people think that aggressive hydration combined with typical procedural blood loss could push the Hgb down by 3gms, or am I fooling myself?
Do people think that aggressive hydration combined with typical procedural blood loss could push the Hgb down by 3gms, or am I fooling myself?
Do people think that aggressive...
02/03/2015
Cath Lab Digest
Clinical Editor's Corner
12/05/2014
Cath Lab Digest
Original Contribution
08/01/2008
Approximately 1 million patients are now treated annually in the United States with drug-eluting stents (DES). Usage of these stents is substantiated in many patient and lesion subsets by their documented relative safety and reduction in...
Approximately 1 million patients are now treated annually in the United States with drug-eluting stents (DES). Usage of these stents is substantiated in many patient and lesion subsets by their documented relative safety and reduction in...
Approximately 1 million patients...
08/01/2008
Journal of Invasive Cardiology
Clinical Editor's Corner
11/14/2013
Cath Lab Digest